Home » Newsletters » BioWorld

BioWorld

Jan. 27, 2009

View Archived Issues

Biotech Reveling in the Stem Cell Effect, Embryonic or not

It's never been so good to be working in the embryonic stem cell space. (BioWorld Today) Read More

Pfizer $68B Bid for Wyeth Leaves Crucell at the Altar

Nearly a Decade Later, RECIST Rules Get Their First Makeover

Investors Balk as Altus Drops Trizytek and Cuts 75% of Staff

Forma Getting up to $54M in Cubist Antibacterial Deal

AC Immune Gets $35M for Alzheimer's Pipeline

Other News To Note

Clinic Roundup